_version_ 1783703876609769472
author Hoeks, Marlijn
Bagguley, Tim
van Marrewijk, Corine
Smith, Alex
Bowen, David
Culligan, Dominic
Kolade, Seye
Symeonidis, Argiris
Garelius, Hege
Spanoudakis, Michail
Langemeijer, Saskia
Roelofs, Rian
Wiegerinck, Erwin
Tatic, Aurelia
Killick, Sally
Panagiotidis, Panagiotis
Stanca, Oana
Hellström-Lindberg, Eva
Cermak, Jaroslav
van der Klauw, Melanie
Wouters, Hanneke
van Kraaij, Marian
Blijlevens, Nicole
Swinkels, Dorine W.
de Witte, Theo
author_facet Hoeks, Marlijn
Bagguley, Tim
van Marrewijk, Corine
Smith, Alex
Bowen, David
Culligan, Dominic
Kolade, Seye
Symeonidis, Argiris
Garelius, Hege
Spanoudakis, Michail
Langemeijer, Saskia
Roelofs, Rian
Wiegerinck, Erwin
Tatic, Aurelia
Killick, Sally
Panagiotidis, Panagiotis
Stanca, Oana
Hellström-Lindberg, Eva
Cermak, Jaroslav
van der Klauw, Melanie
Wouters, Hanneke
van Kraaij, Marian
Blijlevens, Nicole
Swinkels, Dorine W.
de Witte, Theo
author_sort Hoeks, Marlijn
collection PubMed
description
format Online
Article
Text
id pubmed-8179850
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-81798502021-06-17 Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome Hoeks, Marlijn Bagguley, Tim van Marrewijk, Corine Smith, Alex Bowen, David Culligan, Dominic Kolade, Seye Symeonidis, Argiris Garelius, Hege Spanoudakis, Michail Langemeijer, Saskia Roelofs, Rian Wiegerinck, Erwin Tatic, Aurelia Killick, Sally Panagiotidis, Panagiotis Stanca, Oana Hellström-Lindberg, Eva Cermak, Jaroslav van der Klauw, Melanie Wouters, Hanneke van Kraaij, Marian Blijlevens, Nicole Swinkels, Dorine W. de Witte, Theo Leukemia Article Nature Publishing Group UK 2020-09-18 2021 /pmc/articles/PMC8179850/ /pubmed/32948844 http://dx.doi.org/10.1038/s41375-020-01022-2 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Hoeks, Marlijn
Bagguley, Tim
van Marrewijk, Corine
Smith, Alex
Bowen, David
Culligan, Dominic
Kolade, Seye
Symeonidis, Argiris
Garelius, Hege
Spanoudakis, Michail
Langemeijer, Saskia
Roelofs, Rian
Wiegerinck, Erwin
Tatic, Aurelia
Killick, Sally
Panagiotidis, Panagiotis
Stanca, Oana
Hellström-Lindberg, Eva
Cermak, Jaroslav
van der Klauw, Melanie
Wouters, Hanneke
van Kraaij, Marian
Blijlevens, Nicole
Swinkels, Dorine W.
de Witte, Theo
Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome
title Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome
title_full Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome
title_fullStr Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome
title_full_unstemmed Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome
title_short Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome
title_sort toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179850/
https://www.ncbi.nlm.nih.gov/pubmed/32948844
http://dx.doi.org/10.1038/s41375-020-01022-2
work_keys_str_mv AT hoeksmarlijn toxicironspeciesinlowerriskmyelodysplasticsyndromepatientscourseofdiseaseandeffectsonoutcome
AT bagguleytim toxicironspeciesinlowerriskmyelodysplasticsyndromepatientscourseofdiseaseandeffectsonoutcome
AT vanmarrewijkcorine toxicironspeciesinlowerriskmyelodysplasticsyndromepatientscourseofdiseaseandeffectsonoutcome
AT smithalex toxicironspeciesinlowerriskmyelodysplasticsyndromepatientscourseofdiseaseandeffectsonoutcome
AT bowendavid toxicironspeciesinlowerriskmyelodysplasticsyndromepatientscourseofdiseaseandeffectsonoutcome
AT culligandominic toxicironspeciesinlowerriskmyelodysplasticsyndromepatientscourseofdiseaseandeffectsonoutcome
AT koladeseye toxicironspeciesinlowerriskmyelodysplasticsyndromepatientscourseofdiseaseandeffectsonoutcome
AT symeonidisargiris toxicironspeciesinlowerriskmyelodysplasticsyndromepatientscourseofdiseaseandeffectsonoutcome
AT gareliushege toxicironspeciesinlowerriskmyelodysplasticsyndromepatientscourseofdiseaseandeffectsonoutcome
AT spanoudakismichail toxicironspeciesinlowerriskmyelodysplasticsyndromepatientscourseofdiseaseandeffectsonoutcome
AT langemeijersaskia toxicironspeciesinlowerriskmyelodysplasticsyndromepatientscourseofdiseaseandeffectsonoutcome
AT roelofsrian toxicironspeciesinlowerriskmyelodysplasticsyndromepatientscourseofdiseaseandeffectsonoutcome
AT wiegerinckerwin toxicironspeciesinlowerriskmyelodysplasticsyndromepatientscourseofdiseaseandeffectsonoutcome
AT taticaurelia toxicironspeciesinlowerriskmyelodysplasticsyndromepatientscourseofdiseaseandeffectsonoutcome
AT killicksally toxicironspeciesinlowerriskmyelodysplasticsyndromepatientscourseofdiseaseandeffectsonoutcome
AT panagiotidispanagiotis toxicironspeciesinlowerriskmyelodysplasticsyndromepatientscourseofdiseaseandeffectsonoutcome
AT stancaoana toxicironspeciesinlowerriskmyelodysplasticsyndromepatientscourseofdiseaseandeffectsonoutcome
AT hellstromlindbergeva toxicironspeciesinlowerriskmyelodysplasticsyndromepatientscourseofdiseaseandeffectsonoutcome
AT cermakjaroslav toxicironspeciesinlowerriskmyelodysplasticsyndromepatientscourseofdiseaseandeffectsonoutcome
AT vanderklauwmelanie toxicironspeciesinlowerriskmyelodysplasticsyndromepatientscourseofdiseaseandeffectsonoutcome
AT woutershanneke toxicironspeciesinlowerriskmyelodysplasticsyndromepatientscourseofdiseaseandeffectsonoutcome
AT vankraaijmarian toxicironspeciesinlowerriskmyelodysplasticsyndromepatientscourseofdiseaseandeffectsonoutcome
AT blijlevensnicole toxicironspeciesinlowerriskmyelodysplasticsyndromepatientscourseofdiseaseandeffectsonoutcome
AT swinkelsdorinew toxicironspeciesinlowerriskmyelodysplasticsyndromepatientscourseofdiseaseandeffectsonoutcome
AT dewittetheo toxicironspeciesinlowerriskmyelodysplasticsyndromepatientscourseofdiseaseandeffectsonoutcome
AT toxicironspeciesinlowerriskmyelodysplasticsyndromepatientscourseofdiseaseandeffectsonoutcome